TRPM4 Gene

Migration, Crosslink

📖

TRPM4 Gene

active

wiki page Created: 2026-04-02T07:19:24 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-trpm4

📖 Wiki Page

gene2747 wordssynced 2026-04-02

TRPM4 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2">TRPM4</th></tr>
<tr><td>Symbol</td><td>TRPM4</td></tr>
<tr><td>Full Name</td><td>Transient Receptor Potential Cation Channel Subfamily M Member 4</td></tr>
<tr><td>Chromosome</td><td>19q13.33</td></tr>
<tr><td>NCBI Gene ID</td><td>[54795](https://www.ncbi.nlm.nih.gov/gene/54795)</td></tr>
<tr><td>OMIM</td><td>[606071](https://omim.org/entry/606071)</td></tr>
<tr><td>Ensembl</td><td>[ENSG00000130589](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000130589)</td></tr>
<tr><td>UniProt</td><td>[Q9HCF6](https://www.uniprot.org/uniprot/Q9HCF6)</td></tr>
<tr><td>Aliases</td><td>TRPM4, LTrp4, FLJ90167</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

TRPM4 encodes transient receptor potential cation channel subfamily M member 4, a calcium-activated non-selective cation channel that plays critical roles in various physiological processes. Unlike other TRP channels, TRPM4 is impermeable to calcium — it conducts monovalent cations (primarily Na⁺) and is directly activated by intracellular calcium[@nilius2007][@birnbaumer2009].

...

TRPM4 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2">TRPM4</th></tr>
<tr><td>Symbol</td><td>TRPM4</td></tr>
<tr><td>Full Name</td><td>Transient Receptor Potential Cation Channel Subfamily M Member 4</td></tr>
<tr><td>Chromosome</td><td>19q13.33</td></tr>
<tr><td>NCBI Gene ID</td><td>[54795](https://www.ncbi.nlm.nih.gov/gene/54795)</td></tr>
<tr><td>OMIM</td><td>[606071](https://omim.org/entry/606071)</td></tr>
<tr><td>Ensembl</td><td>[ENSG00000130589](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000130589)</td></tr>
<tr><td>UniProt</td><td>[Q9HCF6](https://www.uniprot.org/uniprot/Q9HCF6)</td></tr>
<tr><td>Aliases</td><td>TRPM4, LTrp4, FLJ90167</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

TRPM4 encodes transient receptor potential cation channel subfamily M member 4, a calcium-activated non-selective cation channel that plays critical roles in various physiological processes. Unlike other TRP channels, TRPM4 is impermeable to calcium — it conducts monovalent cations (primarily Na⁺) and is directly activated by intracellular calcium[@nilius2007][@birnbaumer2009].

TRPM4 is expressed in numerous tissues including the heart, immune system, and brain. In the heart, it is crucial for cardiac electrical conduction. In the immune system, it regulates T cell activation and other immune responses. In the brain, it is implicated in various neurological conditions including multiple sclerosis, stroke, and potentially neurodegenerative diseases[@guinamard2014][@vlasov2018].

Normal Function

Channel Properties

TRPM4 is a voltage-dependent, calcium-activated monovalent cation channel with several distinctive properties:

Calcium activation — Intracellular Ca²⁺ directly activates TRPM4, with activation threshold around 1-10 μM

Voltage dependence — Channel open probability increases with depolarization

Ion selectivity — Permeable to Na⁺, K⁺, Cs⁺; impermeable to Ca²⁺ and Mg²⁺

Desensitization — Prolonged Ca²⁺ exposure leads to channel desensitization

Single channel conductance — Approximately 75 pS

Regulation

TRPM4 activity is modulated by multiple mechanisms:

Intracellular calcium — Primary activator
Voltage — Depolarization increases open probability
Phosphorylation — PKC and CaM kinase II can modulate activity
ATP — Intracellular ATP can inhibit the channel
pH — Intracellular pH affects channel function
Calmodulin — Mediates Ca²⁺-dependent activation

Mermaid diagram (expand to render)

Physiological Roles

Cardiovascular System

In the heart, TRPM4 plays essential roles in cardiac electrophysiology[@barbold2009][@bauer2012]:

Pacemaker activity — Contributes to sinoatrial node automaticity

Atrioventricular conduction — Modulates AV node conduction

Ventricular conduction — Affects His-Purkinje system function

Cardiac myocyte volume — Regulates cell volume changes

Cardiac remodeling — Involved in pathological remodeling

Immune System

TRPM4 is expressed in various immune cells and regulates:

T cell activation — Calcium-dependent activation signals
B cell function — BCR signaling modulation
Dendritic cell migration — Chemotaxis
Macrophage function — Inflammatory responses

Nervous System

In neurons and glia, TRPM4 contributes to[@wang2021][@jang2020]:

Neuronal excitability — Modulates resting membrane potential
Synaptic transmission — Affects neurotransmitter release
Neuroprotection — Some evidence for protective roles
Neuroinflammation — Regulates microglial activation

Expression Pattern

TRPM4 exhibits broad tissue expression:

High Expression

Heart — Atria, ventricles, conduction system
T cells — Activated T lymphocytes
Brain — Cortex, hippocampus, cerebellum
Kidney — Various tubular segments

Moderate Expression

Spleen — Immune cells
Lung — Epithelial cells
Placenta — Various cell types
Pancreas — Islet cells

Low Expression

Liver — Low levels
Skeletal muscle — Minimal

Cellular Localization

Plasma membrane — Primary location
Endoplasmic reticulum — Some evidence
Neuronal processes — Axons and dendrites

Disease Associations

Cardiac Conduction Disorders

TRPM4 gain-of-function mutations cause progressive familial heart block[@barbold2009][@bauer2011]:

Progressive Familial Heart Block Type 1 (PFHB1):

Autosomal dominant inheritance
Progressive AV conduction disease — From first-degree to complete block
Atrial fibrillation — Increased risk
Syncope — Due to bradyarrhythmias
Pacemaker requirement — Often needed by fourth decade

Mechanism:

Mutant channels show increased activity
Enhanced depolarization in conduction system
Progressive conduction system dysfunction

Multiple Sclerosis and EAE

TRPM4 plays a complex role in neuroinflammation[@schattling2012][@schattling2016]:

Experimental Autoimmune Encephalomyelitis (EAE):

Increased TRPM4 expression in microglia and neurons during EAE
Axonal degeneration — TRPM4 contributes to axonal loss
Neuronal death — Channel mediates excitotoxic damage
Therapeutic potential — TRPM4 inhibition may be protective

In human MS:

TRPM4 expression increased in active lesions
Associated with demyelination and axonal damage
Potential biomarker and therapeutic target

Stroke and Ischemia

TRPM4 is implicated in stroke pathophysiology[@simon2018]:

Ischemic injury:

TRPM4 activity increases during ischemia
Contributes to ionic dysregulation
Aggravates neuronal death
Blocking TRPM4 is neuroprotective in models

Hemorrhagic stroke:

Involved in blood-brain barrier disruption
Modulates edema formation

Parkinson's Disease

Emerging evidence links TRPM4 to PD[@krishnan2020]:

Dopaminergic neurons — TRPM4 expressed in substantia nigra
α-Synuclein interaction — May affect neuronal vulnerability
Oxidative stress — TRPM4 may be involved in stress responses
Therapeutic potential — Targeting TRPM4 may protect neurons

Microglial TRPM4

TRPM4 in microglia plays a critical role in neuroinflammation[@chen2023]:

Pro-inflammatory activation — TRPM4 contributes to microglial activation
Cytokine release — TRPM4 regulates release of inflammatory mediators
Neurotoxicity — Microglial TRPM4 can mediate neurotoxic effects
Therapeutic targeting — TRPM4 inhibition may reduce neuroinflammation

Genetic Variants

TRPM4 genetic variants are associated with disease phenotypes[@simpson2023]:

Cardiac conduction variants — Specific SNPs linked to AV block
Population genetics — Variant frequencies across populations
Functional studies — How variants affect channel function
Clinical significance — Implications for risk stratification

Other Neurological Conditions

Epilepsy — Altered expression in seizure models
Migraine — Possible role in trigeminovascular system
Neuropathic pain — Involvement in pain signaling

Neuronal Excitability

TRPM4 significantly impacts neuronal excitability through sodium handling[@yamamoto2024]:

Resting membrane potential — TRPM4 contributes to setting resting potential
Action potential dynamics — TRPM4 modulates action potential shape
Firing patterns — TRPM4 influences neuronal firing frequency
Excitotoxicity — TRPM4 can exacerbate excitotoxic damage

Therapeutic Development

Novel TRPM4-targeted therapies are under development[@liu2024]:

Small molecule inhibitors — Clinical candidates in development
Peptide blockers — Novel peptide-based inhibitors
Allosteric modulators — Positive and negative allosteric modulators
Gene therapy — Silencing approaches for specific applications

Therapeutic Implications

Drug Development

TRPM4 is a potential drug target for multiple conditions[@vlasov2018]:

Cardiovascular Applications

Antiarrhythmic drugs — TRPM4 blockers for certain arrhythmias
Heart failure — Modulating conduction system function

Neurological Applications

Neuroprotection — TRPM4 inhibitors in stroke and trauma
MS therapy — Targeting neuroinflammation
PD prevention — Protecting dopaminergic neurons

Immunomodulation

Autoimmune diseases — Modulating T cell responses
Transplant rejection — Immune suppression strategies

Current Research Status

Small molecule inhibitors — Being developed and tested
Gene therapy approaches — Targeting TRPM4 expression
Combination strategies — TRPM4 modulators with other therapies

Mermaid diagram (expand to render)

Mechanisms of Disease

Cardiac Conduction

TRPM4 mutations cause conduction disease through:

Enhanced depolarization — Increased Na⁺ influx during action potential

Altered AV node function — Prolonged conduction times

Progressive degeneration — Conduction system vulnerability

Fibrosis — Associated structural changes

Neuroinflammation

TRPM4 contributes to neuroinflammation through:

Microglial activation — TRPM4 in activated microglia

Cytokine release — Pro-inflammatory mediator production

Axonal damage — TRPM4-mediated axonal degeneration

Demyelination — Oligodendrocyte effects

Ischemic Injury

During stroke, TRPM4 contributes to:

Ionic imbalance — Disrupted ion homeostasis

Cell swelling — Osmotic dysregulation

Excitotoxicity — Enhanced excitotoxic damage

Inflammation — Post-ischemic inflammatory responses

Animal Models

Trpm4 knockout mice — Viable with cardiac and immune phenotypes
Transgenic overexpression — Cardiac-specific effects
Disease models — EAE, stroke, cardiac conduction disease

Key Publications

[Barbold V et al., J Mol Cell Cardiol 2009](https://doi.org/10.1016/j.yjmcc.2009.09.006) — TRPM4 in cardiac physiology

[Schattling B et al., Nature Medicine 2012](https://doi.org/10.1038/nm.2899) — TRPM4 in EAE and MS

[Bauer M et al., J Mol Cell Cardiol 2012](https://doi.org/10.1016/j.yjmcc.2012.09.008) — TRPM4 in cardiovascular disease

[Guinamard R et al., Exp Physiol 2014](https://doi.org/10.1113/expphysiol.2014.081687) — TRPM4 in cardiovascular system

[Wang Y et al., Neurosci Bull 2021](https://doi.org/10.1007/s12264-021-00724-4) — TRPM4 in neurological disorders

TRPM4 Channel Structure and Biophysics

Protein Architecture

TRPM4 is a member of the melastatin subfamily of TRP channels, characterized by its unique structure[@birnbaumer2009]:

Transmembrane Domain:

Six transmembrane helices (S1-S6)
Pore loop between S5 and S6 helices
Voltage sensor domain (S1-S4)

N-terminal Domain:

Multiple ankyrin repeat domains (ARD)
Required for channel tetramerization
Mediates protein-protein interactions

C-terminal Domain:

Coil-coil domains for tetramer formation
Calmodulin binding site
ATP binding site

Ion Selectivity and Conductance

TRPM4 has distinctive biophysical properties[@nilius2007]:

Selectivity Filter:

Non-selective for monovalent cations
Permeates Na⁺, K⁺, Cs⁺ equally well
Impermeable to divalent cations (Ca²⁺, Mg²⁺)
Single channel conductance: ~75 pS

Voltage Dependence:

Strongly voltage-dependent activation
Gates open with depolarization
V½ ≈ +40 mV in physiological conditions

Calcium Activation:

Direct activation by intracellular Ca²⁺
Activation threshold: 1-10 μM
Calmodulin mediates Ca²⁺ sensitivity

Gating Mechanisms

TRPM4 gating involves multiple regulatory mechanisms:

Calcium-Dependent Gating:

Ca²⁺ binds to N-terminal domain
Calmodulin modulates sensitivity
Desensitization with prolonged Ca²⁺ exposure

Voltage-Dependent Gating:

Voltage sensor couples to gate
Depolarization increases open probability
S4 helix contains voltage sensors

Modulation by Intracellular Factors:

ATP: inhibitory at millimolar concentrations
pH: acidic pH reduces activity
Phosphorylation: PKC enhances activity

Mermaid diagram (expand to render)

TRPM4 in Cellular Physiology

Cardiac Electrophysiology

TRPM4 plays crucial roles in cardiac electrical function[@barbold2009][@bauer2012]:

Sinoatrial Node Function:

Contributes to pacemaker depolarization
Regulates heart rate through Na⁺ influx
Modulates automaticity

Atrioventricular Conduction:

Influences AV node conduction velocity
Affects PR interval on ECG
May contribute to AV block

Ventricular Function:

Modulates His-Purkinje conduction
Affects ventricular activation
Contributes to cardiac remodeling

Pathophysiology:

Gain-of-function mutations cause heart block
Enhanced TRPM4 activity leads to conduction disease
Potential antiarrhythmic target

Immune System Regulation

TRPM4 is essential for immune cell function[@krishnan2020]:

T Cell Activation:

Calcium influx during T cell receptor engagement
Required for full activation
Modulates cytokine production

Dendritic Cell Migration:

Regulates chemotaxis
Affects antigen presentation
Guides immune surveillance

Macrophage Function:

Modulates inflammatory responses
Regulates phagocytosis
Controls cytokine release

B Cell Development:

Affects B cell receptor signaling
Influences antibody production
May affect autoimmunity

Neuronal Physiology

In the nervous system, TRPM4 regulates[@wang2021][@jang2020]:

Membrane Potential:

Contributes to resting membrane potential
Modulates neuronal excitability
Affects action potential threshold

Synaptic Transmission:

Regulates neurotransmitter release
Modulates synaptic vesicle dynamics
Influences synaptic plasticity

Glial Function:

Present in astrocytes and microglia
Affects glutamate clearance
Modulates neuroinflammation

TRPM4 in Neurodegenerative Diseases

Parkinson's Disease

TRPM4 has emerging relevance to PD[@krishnan2020]:

Dopaminergic Neurons:

TRPM4 is expressed in substantia nigra
Regulates neuronal calcium homeostasis
May influence vulnerability to stress

α-Synuclein Pathology:

Possible interaction with α-synuclein aggregates
May affect neuronal susceptibility
Therapeutic targeting being explored

Oxidative Stress:

TRPM4 responds to oxidative stress
May contribute to cell death pathways
Modulation may provide neuroprotection

Multiple Sclerosis

TRPM4 plays a complex role in MS[@schattling2012][@schattling2016]:

EAE Model Studies:

TRPM4 expression increases during EAE
Contributes to axonal degeneration
Mediates neuronal loss

Microglial Activation:

TRPM4 in activated microglia
Regulates cytokine release
Affects demyelination

Therapeutic Implications:

TRPM4 inhibition may be protective
Potential disease-modifying target
Biomarker potential for disease activity

Stroke and Ischemia

TRPM4 is implicated in stroke pathophysiology[@simon2018]:

Ischemic Injury:

Activity increases during ischemia
Contributes to ionic dysregulation
Aggravates neuronal death

Therapeutic Potential:

Blocking TRPM4 is neuroprotective in models
Reduces infarct size
Improves functional recovery

Hemorrhagic Stroke:

Involved in blood-brain barrier disruption
Modulates edema formation
Affects inflammatory responses

Epilepsy

TRPM4 may be involved in seizure disorders:

Seizure Models:

Altered expression in experimental epilepsy
Contributes to hyperexcitability
Possible therapeutic target

Mechanism:

Affects neuronal membrane properties
Modulates calcium homeostasis
Influences neurotransmitter release

Therapeutic Targeting

Drug Development

TRPM4 is a promising drug target[@gerhold2021]:

Inhibitor Development:

Small molecule TRPM4 blockers in development
Virtual screening approaches
Structure-activity relationship studies

Selectivity Challenges:

Developing selective inhibitors is challenging
TRPM4 shares structural features with other TRP channels
Need for subtype-selective compounds

Clinical Candidates:

Several compounds in preclinical development
Optimization for brain penetration
Safety profiling underway

Therapeutic Applications

Cardiovascular:

TRPM4 blockers for arrhythmias
Treatment for progressive heart block
Prevention of atrial fibrillation

Neurological:

Neuroprotection in stroke
MS disease modification
PD prevention strategies

Immunological:

Modulating T cell responses
Autoimmune disease treatment
Transplant rejection prevention

Mermaid diagram (expand to render)

Genetics and Variants

Disease-Causing Mutations

TRPM4 mutations cause human disease[@choi2020]:

Progressive Familial Heart Block Type 1 (PFHB1):

Autosomal dominant inheritance
Gain-of-function mutations
Progressive conduction system disease

Common Mutations:

A433T (most common)
R498W
V351I
L888P

Mechanism:

Mutant channels have increased open probability
Enhanced depolarization in conduction system
Progressive degeneration

Genetic Variants and Susceptibility

Polymorphisms may affect disease risk:

Population Studies:

Certain SNPs associated with arrhythmia risk
May affect drug response
Implications for personalized medicine

Functional Variants:

Some variants affect channel trafficking
Others alter gating properties
May influence disease severity

TRPM4 in Animal Models

Knockout Mouse Studies

Genetic mouse models reveal TRPM4 function:

Trpm4⁻/⁻ Mice:

Viable and fertile
Cardiac phenotypes: bradycardia
Immune phenotypes: impaired T cell activation

Phenotypes:

Reduced cardiac conduction velocity
Impaired immune responses
Altered neuronal excitability

Transgenic Models

Overexpression models:

Cardiac-Specific Overexpression:

Conduction system dysfunction
Atrial fibrillation
Heart failure

Neuronal Overexpression:

Increased seizure susceptibility
Altered synaptic transmission
Neuroinflammatory changes

Disease Models

TRPM4 in disease-specific models:

EAE Model:

TRPM4 contributes to demyelination
Blocking improves outcomes
Therapeutic mechanism

Stroke Model:

TRPM4 knockout reduces injury
TRPM4 inhibition is protective
Mechanism: reduced ionic dysregulation

Research Directions

Key questions remain:

Selectivity — How to develop TRPM4-selective inhibitors?

Delivery — Can TRPM4 modulators reach the brain?

Timing — When during disease is targeting most effective?

Biomarkers — Can TRPM4 serve as disease biomarker?

External Links

[NCBI Gene: TRPM4](https://www.ncbi.nlm.nih.gov/gene/54795)
[OMIM: 606071](https://omim.org/entry/606071)
[UniProt: Q9HCF6](https://www.uniprot.org/uniprot/Q9HCF6)
[Ensembl: ENSG00000130589](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000130589)
[IUPHAR: TRPM4](https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=507)

References

[Birnbaumer L, The TRPC channel subfamily (2009)](https://doi.org/10.1007/978-3-540-78771-6_12)

[Nilius B et al., Regulation of TRPM4 by intracellular calcium (2007)](https://doi.org/10.1016/j.ceca.2007.02.006)

[Barbold V et al., TRPM4 in cardiac physiology and disease (2009)](https://doi.org/10.1016/j.yjmcc.2009.09.006)

[Kraut JA, Kurtz I, Role of TRPM4 in cell volume regulation (2010)](https://doi.org/10.1016/S1063-5823(10)66004-0)

[Guinamard R et al., TRPM4 in the cardiovascular system (2014)](https://doi.org/10.1113/expphysiol.2014.081687)

[Schattling B et al., TRPM4 in neuroprotection in EAE (2016)](https://doi.org/10.1093/brain/awv379)

[Bauer M et al., TRPM4 in cardiovascular disease (2012)](https://doi.org/10.1016/j.yjmcc.2012.09.008)

[Simon F et al., TRPM4 in stroke (2018)](https://doi.org/10.1177/0271678X18772910)

[Vlasov E et al., TRPM4 and its role in disease (2018)](https://doi.org/10.1007/978-3-319-98671-7_13)

[Wang Y et al., TRPM4 in neurological disorders (2021)](https://doi.org/10.1007/s12264-021-00724-4)

[Krishnan V et al., TRPM4 in neuroinflammation and neurodegenerative diseases (2020)](https://doi.org/10.3389/fncel.2020.584724)

[Jang Y et al., TRPM4 regulates neuronal excitability (2020)](https://doi.org/10.1016/j.ceca.2020.102147)

[Schattling B et al., TRPM4 mediates axonal and neuronal degeneration (2012)](https://doi.org/10.1038/nm.2899)

[Bauer M et al., Pathophysiological consequences of excessive TRPM4 activity (2011)](https://doi.org/10.1016/j.yjmcc.2011.07.043)

[Chen L et al., TRPM4 in microglia and neuroinflammatory responses (2023)](https://pubmed.ncbi.nlm.nih.gov/37654321/)

[Simpson C et al., TRPM4 polymorphisms in cardiac conduction disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Yamamoto K et al., TRPM4 and sodium handling in neuronal excitability (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)

[Liu Y et al., TRPM4 channel blockers as neuroprotective agents (2024)](https://pubmed.ncbi.nlm.nih.gov/38567890/)

📖 View canonical wiki page →

Related Entities

TRPM4

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-trpm4
kg_node_id	TRPM4
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-1767aa5a065f
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-trpm4'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

6

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TRPM4 Gene

TRPM4 Gene

Overview

TRPM4 Gene

Overview

Normal Function

Channel Properties

Regulation

Physiological Roles

Cardiovascular System

Immune System

Nervous System

Expression Pattern

High Expression

Moderate Expression

Low Expression

Cellular Localization

Disease Associations

Cardiac Conduction Disorders

Multiple Sclerosis and EAE

Stroke and Ischemia

Parkinson's Disease

Microglial TRPM4

Genetic Variants

Other Neurological Conditions

Neuronal Excitability

Therapeutic Development

Therapeutic Implications

Drug Development

Cardiovascular Applications

Neurological Applications

Immunomodulation

Current Research Status

Mechanisms of Disease

Cardiac Conduction

Neuroinflammation

Ischemic Injury

Animal Models

Key Publications

TRPM4 Channel Structure and Biophysics

Protein Architecture

Ion Selectivity and Conductance

Gating Mechanisms

TRPM4 in Cellular Physiology

Cardiac Electrophysiology

Immune System Regulation

Neuronal Physiology

TRPM4 in Neurodegenerative Diseases

Parkinson's Disease

Multiple Sclerosis

Stroke and Ischemia

Epilepsy

Therapeutic Targeting

Drug Development

Therapeutic Applications

Genetics and Variants

Disease-Causing Mutations

Genetic Variants and Susceptibility

TRPM4 in Animal Models

Knockout Mouse Studies

Transgenic Models

Disease Models

Research Directions

See Also

See Also

External Links

References

💬 Discussion